Results 141 to 150 of about 8,213,046 (356)

PYCR1 inhibition in bone marrow stromal cells enhances bortezomib sensitivity in multiple myeloma cells by altering their metabolism

open access: yesMolecular Oncology, EarlyView.
This study investigated how PYCR1 inhibition in bone marrow stromal cells (BMSCs) indirectly affects multiple myeloma (MM) cell metabolism and viability. Culturing MM cells in conditioned medium from PYCR1‐silenced BMSCs impaired oxidative phosphorylation and increased sensitivity to bortezomib.
Inge Oudaert   +13 more
wiley   +1 more source

Assessing Affirmative Action Practices in Nepal’s Federal Civil Service: Current Achievements and Future Reform Needs

open access: yesNepal Public Policy Review
Nepal has implemented an affirmative action policy in the federal civil service since 2007 to address historical injustices and inequalities and promote the representation of marginalized people, such as women, ethnic minorities, and underprivileged ...
Baburam Bhul
doaj   +1 more source

Mongolia-Australia relations: a Mongolian perspective [PDF]

open access: yes
With this year marking the 40th anniversary of Mongolia–Australia relations, this paper looks at the background of relations, educational investment, economic interests and political and security ties.
Mendee Jargalsaikhan
core  

Kultivating Kultur: increasing arts research deposit [PDF]

open access: yes, 2012
This paper presents research undertaken as part of the JISC-funded Kultivate project and discusses how it is encouraging arts research deposit in UK institutional repositories.
Gramstadt, Marie-Therese
core   +1 more source

In vitro properties of patient serum predict clinical outcome after high dose rate brachytherapy of hepatocellular carcinoma

open access: yesMolecular Oncology, EarlyView.
Following high dose rate brachytherapy (HDR‐BT) for hepatocellular carcinoma (HCC), patients were classified as responders and nonresponders. Post‐therapy serum induced increased BrdU incorporation and Cyclin E expression of Huh7 and HepG2 cells in nonresponders, but decreased levels in responders.
Lukas Salvermoser   +14 more
wiley   +1 more source

Predator-in-Chief: Wolves in Editors’ Clothing

open access: yesPlastic and Reconstructive Surgery, Global Open, 2018
Rod J. Rohrich, MD   +1 more
doaj   +1 more source

Modelling Open Plan Offices

open access: yes, 2022
The current document describes the research work carried out in the Applied Acoustics Department of Chalmers University of Technology (Gothenburg, Sweden). It corresponds to the study of two acoustic simulation softwares that are, in the moment of the project, under tests The present work is one of them, focused on the “Modelling of Open Plan Offices”,
openaire   +2 more sources

Inhibition of CDK9 enhances AML cell death induced by combined venetoclax and azacitidine

open access: yesMolecular Oncology, EarlyView.
The CDK9 inhibitor AZD4573 downregulates c‐MYC and MCL‐1 to induce death of cytarabine (AraC)‐resistant AML cells. This enhances VEN + AZA‐induced cell death significantly more than any combination of two of the three drugs in AraC‐resistant AML cells.
Shuangshuang Wu   +18 more
wiley   +1 more source

A Major Milestone for Plastic and Reconstructive Surgery—Global Open: Indexing and Archiving in PubMed Central

open access: yesPlastic and Reconstructive Surgery, Global Open, 2015
Rod J. Rohrich, MD, Aaron Weinstein, MS
doaj   +1 more source

Home - About - Disclaimer - Privacy